Target intelligence / Profile preview

BCL2 interacting protein 3 pseudogene 39 (BNIP3P39)

Target
BNIP3P39
Molecular classification
Other (pseudogene)
01

Overview

BCL2 interacting protein 3 pseudogene 39 (BNIP3P39) is a pseudogene annotated in the human genome. It carries sequence similarity to the BNIP3 protein-coding gene, which is involved in apoptosis and autophagy, but BNIP3P39 itself does not produce a functional protein and is not implicated in known biological pathways, disease processes, or therapeutic mechanisms[1][2][8]. There is no evidence that BNIP3P39 is a receptor, enzyme, transporter, transcription factor, or clinical biomarker. The designation and aliases simply reflect sequence similarity to the real target BNIP3, but BNIP3P39 is not a valid therapeutic target. *Note: The closely related BNIP3 gene (not BNIP3P39) is a protein-coding gene involved in apoptosis, cell death, and mitophagy, and is an established cancer-relevant target, but BNIP3P39 specifically refers to a pseudogene and not the protein-coding gene or functional protein[3][10].*

Other names
BCL2/adenovirus E1B 19kDa interacting protein 3 pseudogene 39BNIP3P39
02

Mechanism of action

null (no drugs known to act via BNIP3P39; as a pseudogene, it is not a mechanism-based target)

Beyond the preview

Go deeper on BCL2 interacting protein 3 pseudogene 39 (BNIP3P39).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on BCL2 interacting protein 3 pseudogene 39 (BNIP3P39).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call